Metropolitan Life Insurance Company (MetLife)’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-6,810
| Closed | -$511K | – | 2539 |
|
|
2021
Q4 | $511K | Sell |
6,810
-53
| -0.8% | -$3.98K | 0.01% | 1407 |
|
|
2021
Q3 | $797K | Buy |
+6,863
| New | +$797K | 0.01% | 1130 |
|
|
2021
Q2 | – | Sell |
-7,322
| Closed | -$968K | – | 2821 |
|
|
2021
Q1 | $968K | Sell |
7,322
-330
| -4% | -$43.6K | 0.01% | 944 |
|
|
2020
Q4 | $1.32M | Sell |
7,652
-45
| -0.6% | -$7.79K | 0.02% | 696 |
|
|
2020
Q3 | $857K | Sell |
7,697
-199
| -3% | -$22.2K | 0.01% | 835 |
|
|
2020
Q2 | $468K | Sell |
7,896
-18,288
| -70% | -$1.08M | 0.01% | 1258 |
|
|
2020
Q1 | $1.76M | Sell |
26,184
-568
| -2% | -$38.2K | 0.04% | 432 |
|
|
2019
Q4 | $2.25M | Sell |
26,752
-738
| -3% | -$62.2K | 0.04% | 477 |
|
|
2019
Q3 | $2.06M | Buy |
27,490
+4,041
| +17% | +$302K | 0.03% | 490 |
|
|
2019
Q2 | $1.48M | Hold |
23,449
| – | – | 0.03% | 668 |
|
|
2019
Q1 | $1.13M | Buy |
+23,449
| New | +$1.13M | 0.02% | 822 |
|